Literature DB >> 11768725

Associations of plasma endothelin concentration with carotid atherosclerosis and asymptomatic cerebrovascular lesions in patients with essential hypertension.

S Minami1, S Yamano, Y Yamamoto, R Sasaki, T Nakashima, M Takaoka, T Hashimoto.   

Abstract

We studied the association of endothelin (ET)-1 with carotid atherosclerosis and asymptomatic cerebrovascular lesions in patients with essential hypertension. Neurologically normal patients with essential hypertension (n=293; 138 male, 155 female; mean age, 65 years) and age-matched control subjects (n=242) were studied with B-mode ultrasonography of the common and internal carotid arteries and magnetic resonance imaging of the brain. Plasma ET-1 was measured by enzyme immunoassay. Hypertensive patients were divided into groups with carotid plaques and low ET-1 concentrations (< 0.75 pg/ml; PL group); carotid plaques and mid-range ET-1 (0.75 to 1.55 pg/ml; PM group); carotid plaques and high ET-1 (> or = 1.55 pg/ml; PH group); no plaques and low ET-1 (NPL); no plaques and mid-range ET-1 (NPM); and no plaques and high ET-1 (NPH). Overall, ET-1 concentrations were significantly higher in patients than in control subjects. Carotid plaque prevalence was significantly related to ET-1 in hypertensive patients. ET-1 showed a significant positive relationship with the number of asymptomatic lacunar infarcts of the brain in hypertensive patients with carotid plaques (rho=0.48, p<0.001). No significant relationship was seen between ET-1 and periventricular hyperintensity scores in patients with plaques. ET-1 did not show a relationship to either brain lesion type in patients without carotid plaques. Thus, ET-1 may foster asymptomatic lacunar cerebral infarcts by promoting carotid atherosclerosis in patients with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11768725     DOI: 10.1291/hypres.24.663

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  4 in total

1.  Olmesartan improves endothelin-induced hypertension and oxidative stress in rats.

Authors:  Li Yao; Hiroyuki Kobori; Matlubur Rahman; Dale M Seth; Takatomi Shokoji; Yuyan Fan; Guo-Xing Zhang; Shoji Kimura; Youichi Abe; Akira Nishiyama
Journal:  Hypertens Res       Date:  2004-07       Impact factor: 3.872

2.  Genetic Polymorphisms in Endothelin-1 as Predictors for Long-Term Survival and the Cardiac Index in Patients Undergoing On-Pump Cardiac Surgery.

Authors:  Ashham Mansur; Maximilian Steinau; Aron Frederik Popov; Sinisa Milenovic; Christian Bireta; Alexander Weymann; Hanna Schotola; Christoph H Wiese; Tim Beissbarth; Mladen Tzvetkov; José Hinz
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

3.  Impaired dynamic cerebral autoregulation is associated with the severity of neuroimaging features of cerebral small vessel disease.

Authors:  Zhaojun Liu; Hongyin Ma; Zhen-Ni Guo; Le Wang; Yang Qu; Lei Fan; Xingliang Liu; Jie Liu; Yuanyuan Zhu; Yi Yang
Journal:  CNS Neurosci Ther       Date:  2021-12-11       Impact factor: 5.243

4.  Associations of genetic variants of endothelin with cardiovascular complications in patients with renal failure.

Authors:  Chih-Chin Kao; Shih-Ying Cheng; Mei-Yi Wu; Shu-Chen Chien; Hsing-Fang Lu; Yu-Wen Hsu; Yan-Feng Zhang; Mai-Szu Wu; Wei-Chiao Chang
Journal:  BMC Nephrol       Date:  2017-09-07       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.